Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1998-04-14
1999-03-02
Achutamurthy, Ponnathapura
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
435 71, A61K 3921, G01N 3353
Patent
active
058767320
ABSTRACT:
A novel cell line chronically infected with HIV-2.sub.NIHZ virus secretes the precursor of the viral envelope proteins in extracellular medium. The cells grow well in serum-free medium which enables the concentration of the conditioned medium of the cells to be greatly increased (>100 fold). Such a concentration step is otherwise impossible to achieve if the cells are grown under conventional conditions using 10% fetal calf serum. A specific affinity procedure is provided to purify the gp160 protein from the concentrated conditioned medium of cultures of 100 liter batches using a mouse monoclonal antibody to the HIV-2 gp41 protein, which is a part of the gp160 protein. This purified HIV-2 gp160 reacts with high specificity and sensitivity with the anti viral antibodies of HIV-2 infected humans by several criteria such as i) ELISA, ii) western blot analysis, and iii) radioimmuno-precipitation of metabolically labeled gp160 from the same cell line. The purified HIV-2 gp160 from this cell line is therefore a diagnostic tool for the detection of HIV-2 infection in humans. In view of the predicted oligomeric property of gp160 and its close conformational similarity to the virion envelope, the purified gp160 can also be useful for the development of vaccine strategies against HIV-2 in humans.
REFERENCES:
patent: 5116740 (1992-05-01), Sarngadharan et al.
patent: 5122468 (1992-06-01), Sarnagadharan et al.
Fahey et al., Clin. Exp. Immunol., 88:1-5, 1992.
Fox et al., Biotechnology, 12:128, 1994.
Getchell et al., J. Clin. Microbiol., 23:4:737-742, 1986.
Robey et al., Proc. Natl. Acad. Sci., 83:7023-7027, 1986.
Rey et al., J. Virol., 63:2:647-658, 1989.
Kalyanaraman Vaniambadi S.
LaRue-Kalisz Irene
Sarngadharan Mangalasseril G.
Achutamurthy Ponnathapura
Akzo Nobel N.V.
Gormley Mary E.
Park Hankyd T.
LandOfFree
Human T-cell line infected with HIV-2 which secretes functionall does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human T-cell line infected with HIV-2 which secretes functionall, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human T-cell line infected with HIV-2 which secretes functionall will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-419917